Nls Pharmaceutics Ag Stock Market Value
| NLSPW Stock | USD 0.01 0 22.22% |
| Symbol | NLS |
NLS Pharmaceutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NLS Pharmaceutics. If investors know NLS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NLS Pharmaceutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (2.28) |
The market value of NLS Pharmaceutics is measured differently than its book value, which is the value of NLS that is recorded on the company's balance sheet. Investors also form their own opinion of NLS Pharmaceutics' value that differs from its market value or its book value, called intrinsic value, which is NLS Pharmaceutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NLS Pharmaceutics' market value can be influenced by many factors that don't directly affect NLS Pharmaceutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NLS Pharmaceutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NLS Pharmaceutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NLS Pharmaceutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NLS Pharmaceutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NLS Pharmaceutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NLS Pharmaceutics.
| 11/13/2024 |
| 12/13/2024 |
If you would invest 0.00 in NLS Pharmaceutics on November 13, 2024 and sell it all today you would earn a total of 0.00 from holding NLS Pharmaceutics AG or generate 0.0% return on investment in NLS Pharmaceutics over 30 days. NLS Pharmaceutics is related to or competes with Reviva Pharmaceuticals, GeoVax Labs, and NLS Pharmaceutics. NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat r... More
NLS Pharmaceutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NLS Pharmaceutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NLS Pharmaceutics AG upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 26.97 | |||
| Information Ratio | 0.1138 | |||
| Maximum Drawdown | 190.13 | |||
| Value At Risk | (37.50) | |||
| Potential Upside | 90.0 |
NLS Pharmaceutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NLS Pharmaceutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NLS Pharmaceutics' standard deviation. In reality, there are many statistical measures that can use NLS Pharmaceutics historical prices to predict the future NLS Pharmaceutics' volatility.| Risk Adjusted Performance | 0.0948 | |||
| Jensen Alpha | 3.41 | |||
| Total Risk Alpha | (0.82) | |||
| Sortino Ratio | 0.1482 | |||
| Treynor Ratio | 0.608 |
NLS Pharmaceutics Backtested Returns
NLS Pharmaceutics is out of control given 3 months investment horizon. NLS Pharmaceutics has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 4.54% are justified by taking the suggested risk. Use NLS Pharmaceutics Risk Adjusted Performance of 0.0948, mean deviation of 23.17, and Market Risk Adjusted Performance of 0.618 to evaluate company specific risk that cannot be diversified away. NLS Pharmaceutics holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 6.74, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NLS Pharmaceutics will likely underperform. Use NLS Pharmaceutics downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to analyze future returns on NLS Pharmaceutics.
Auto-correlation | -0.64 |
Very good reverse predictability
NLS Pharmaceutics AG has very good reverse predictability. Overlapping area represents the amount of predictability between NLS Pharmaceutics time series from 13th of November 2024 to 28th of November 2024 and 28th of November 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NLS Pharmaceutics price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current NLS Pharmaceutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.64 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
NLS Pharmaceutics lagged returns against current returns
Autocorrelation, which is NLS Pharmaceutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NLS Pharmaceutics' stock expected returns. We can calculate the autocorrelation of NLS Pharmaceutics returns to help us make a trade decision. For example, suppose you find that NLS Pharmaceutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NLS Pharmaceutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NLS Pharmaceutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NLS Pharmaceutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NLS Pharmaceutics stock over time.
Current vs Lagged Prices |
| Timeline |
NLS Pharmaceutics Lagged Returns
When evaluating NLS Pharmaceutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NLS Pharmaceutics stock have on its future price. NLS Pharmaceutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NLS Pharmaceutics autocorrelation shows the relationship between NLS Pharmaceutics stock current value and its past values and can show if there is a momentum factor associated with investing in NLS Pharmaceutics AG.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.